What is NDC 42291-715?

42291-715 is the product NDC for Ropinirole Hydrochloride, Ropinirole hydrochloride 6 mg/1 tablet, film coated, extended release, listed with the FDA by AvKARE. It has 1 package NDC, shown above in 10- and 11-digit form.

AvKARE, NDC labeler code 42291. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ropinirole Hydrochloride?

37 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ropinirole Hydrochloride NDC 42291-715

NDC codes

FDA NDC Directory

Product NDC (as listed)42291-715Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42291-0715Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42291-715-30	4229107153042291071530	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-715-30)Marketed from Nov 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ropinirole Hydrochloride
Generic name (nonproprietary): ropinirole hydrochloride
Active ingredients: Ropinirole hydrochloride — 6 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: AvKARENDC labeler code 42291
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090869
Marketing start: Sep 13, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine Agonists (Mechanism)
Identifiers: Product ID 42291-715_2b47ad1c-e1cb-7b8b-e063-6394a90aee3cSPL ID 2b47ad1c-e1cb-7b8b-e063-6394a90aee3cSPL set ID abd344d9-7635-62a2-d4e1-38fc46937397RxCUI 799054, 799055, 799056, 824959, 848582UNII D7ZD41RZI9UPC 0342291716308, 0342291717305, 0342291714304, 0342291715301, 0342291713307
Pharmacologic class: Nonergot Dopamine Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442291071530 followed by a unit qualifier and the quantity

Package 42291-0715-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 9, 2025.

Indications (excerpt from the label)

Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease. Ropinirole extended-release tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42291-715

What is NDC 42291-715?: 42291-715 is the product NDC for Ropinirole Hydrochloride, Ropinirole hydrochloride 6 mg/1 tablet, film coated, extended release, listed with the FDA by AvKARE. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ropinirole Hydrochloride.
What is the active ingredient?: Ropinirole hydrochloride.
Who is the labeler?: AvKARE, NDC labeler code 42291. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ropinirole Hydrochloride?: 37 other product NDCs are listed under this name. See all Ropinirole Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ropinirole Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
ropinirole hydrochloride	Ropinirole hydrochloride .25 mg/1	Tablet, Film coatedOral	AvPAK	50268-741	50268-0741-15
ropinirole hydrochloride	Ropinirole hydrochloride .5 mg/1	Tablet, Film coatedOral	AvPAK	50268-742	50268-0742-15
ropinirole hydrochloride	Ropinirole hydrochloride 1 mg/1	Tablet, Film coatedOral	AvPAK	50268-743	50268-0743-15
ropinirole hydrochloride	Ropinirole hydrochloride 2 mg/1	Tablet, Film coatedOral	AvPAK	50268-744	50268-0744-15
ropinirole hydrochloride	Ropinirole hydrochloride .25 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-577	60687-0577-01
ropinirole hydrochloride	Ropinirole hydrochloride 1 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-588	60687-0588-01
ropinirole hydrochloride	Ropinirole hydrochloride .25 mg/1	Tablet, Film coatedOral	Northwind Health Company, LLC	51655-360	51655-0360-26
Ropinirole Hydrochloride	Ropinirole hydrochloride .25 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8188	00615-8188-39
Ropinirole Hydrochloride	Ropinirole hydrochloride .5 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8189	00615-8189-39
Ropinirole Hydrochloride	Ropinirole hydrochloride 1 mg/1	Tablet, Film coatedOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8190	00615-8190-39

All 38 Ropinirole Hydrochloride NDCs

Other NDCs under ANDA 090869

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090869
Product	Strength	Form · route	Labeler	Product NDC
Ropinirole	Ropinirole hydrochloride 6 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	0228-3640
Ropinirole	Ropinirole hydrochloride 2 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	0228-3658
Ropinirole	Ropinirole hydrochloride 4 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	0228-3659
Ropinirole	Ropinirole hydrochloride 8 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	0228-3660
Ropinirole	Ropinirole hydrochloride 12 mg/1	Tablet, Film coated, Extended releaseOral	Actavis Pharma, Inc.	0228-3661
Ropinirole Hydrochloride	Ropinirole hydrochloride 2 mg/1	Tablet, Film coated, Extended releaseOral	AvKARE	42291-713
Ropinirole Hydrochloride	Ropinirole hydrochloride 4 mg/1	Tablet, Film coated, Extended releaseOral	AvKARE	42291-714
Ropinirole Hydrochloride	Ropinirole hydrochloride 8 mg/1	Tablet, Film coated, Extended releaseOral	AvKARE	42291-716
Ropinirole Hydrochloride	Ropinirole hydrochloride 12 mg/1	Tablet, Film coated, Extended releaseOral	AvKARE	42291-717